Hint mode is switched on Switch off

BioCryst Pharmaceuticals, ordinary share
US09058V1035, BCRX

Add a stock to WL
Choose all Reset all
BioCryst Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

explore the most comprehensive database

900 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest quotes

Analysts forecasts

Issuer

  • Issuer
  • Full borrower / issuer name
    BioCryst Pharmaceuticals, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BCRX
  • Placement
    01.08.2018
  • Lock up period
    180
  • Number of papers
    8,474,576
  • Volume of raised funds
    50 mln USD
  • Placement share
    7.89%
  • Final placement price
    5.9 USD
  • Price change since placement date
    75.76%
  • By capitalization
    633.67 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BCRX
  • Placement
    29.05.2020
  • Lock up period
    180
  • Number of papers
    18,711,113
  • Volume of raised funds
    84.2 mln USD
  • Placement share
    10.81%
  • Final placement price
    4.5 USD
  • Price change since placement date
    130.44%
  • By capitalization
    778.8 mln USD

IFRS/US GAAP reports

2024
I q eng
II q eng
III q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Related Stock indices

Indicators

News

14/05/2025 BioCryst Pharmaceuticals: Other Events, Financial Statements And Exhibits
05/05/2025 BioCryst Pharmaceuticals: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
30/04/2025 BioCryst Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
10/03/2025 BioCryst Pharmaceuticals: Other Events
28/02/2025 BioCryst Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
All organization news

Holders

Industry Leaders

Registration is required to get access.